Cristina Cartiglia
Overview
Explore the profile of Cristina Cartiglia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
712
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Izzotti A, Larghero P, Cartiglia C, Longobardi M, Pfeffer U, Steele V, et al.
Carcinogenesis
. 2010 Feb;
31(5):894-901.
PMID: 20145010
Although microRNAs (miRNA) have extensively been investigated in cancer research, less attention has been paid to their regulation by carcinogens and/or protective factors in early stages of the carcinogenesis process....
12.
Izzotti A, Longobardi M, Cartiglia C, DAgostini F, Kanitz S, De Flora S
Curr Cancer Drug Targets
. 2010 Jan;
10(2):147-54.
PMID: 20088799
Among endocrine disruptors, the xenoestrogen bisphenol A (BPA) is of particular interest due to the very high production and widespread environmental contamination. We recently demonstrated that the oral administration of...
13.
Izzotti A, Calin G, Steele V, Cartiglia C, Longobardi M, Croce C, et al.
Cancer Prev Res (Phila)
. 2010 Jan;
3(1):62-72.
PMID: 20051373
We previously showed that exposure to environmental cigarette smoke (ECS) for 28 days causes extensive downregulation of microRNA expression in the lungs of rats, resulting in the overexpression of multiple...
14.
Methodology for evaluating oxidative DNA damage and metabolic genotypes in human trabecular meshwork
Izzotti A, Cartiglia C, De Flora S, Sacca S
Toxicol Mech Methods
. 2009 Dec;
13(3):161-8.
PMID: 20021156
In vitro studies have suggested the possible role of oxidative DNA damage in degenerative eye diseases such as glaucoma. We propose a method aimed at evaluating the oxidative molecular damage...
15.
Izzotti A, DAgostini F, Larghero P, Cartiglia C, Travaini G, Balansky R, et al.
Oncol Rep
. 2009 Jul;
22(3):469-74.
PMID: 19639190
Mice are particularly susceptible to carcinogens when exposure starts early in life. We evaluated the expression of stem cell antigen-1 (Sca-1) gene in the lung of variously aged CD-1 mice,...
16.
Izzotti A, Sacca S, Longobardi M, Cartiglia C
Invest Ophthalmol Vis Sci
. 2009 Jun;
50(11):5251-8.
PMID: 19516005
Purpose: The anterior chamber of the eye is a highly specialized structure delimited by the cornea, lens, and iris. It contains the aqueous humor, secreted by the ciliary body and...
17.
Izzotti A, Pulliero A, Orcesi S, Cartiglia C, Longobardi M, Capra V, et al.
Brain Pathol
. 2008 Nov;
19(4):650-60.
PMID: 19016741
Aicardi-Goutières syndrome (AGS) is a rare interferon (IFN)-related encephalopathy with onset during the first year of life. AGS, is clinically characterized by progressive microcephaly, bilateral basal ganglia calcification, cerebral atrophy,...
18.
De Flora S, DAgostini F, Balansky R, Camoirano A, Cartiglia C, Longobardi M, et al.
Mutat Res
. 2007 Dec;
659(1-2):137-46.
PMID: 18155953
Our recent studies have shown that both cigarette smoke and UV-containing light, which are the most widespread and ubiquitous mutagens and carcinogens in the world, cause systemic genotoxic damage in...
19.
Izzotti A, De Flora S, Cartiglia C, Are B, Longobardi M, Camoirano A, et al.
Carcinogenesis
. 2006 Nov;
28(4):892-8.
PMID: 17127715
Infection by Helicobacter pylori is the most important risk factor for gastric cancer. However, only a small fraction of colonized individuals, representing at least half of the world's population, develop...
20.
Izzotti A, Bagnasco M, Cartiglia C, Longobardi M, Camoirano A, Tampa E, et al.
Mutat Res
. 2005 Aug;
591(1-2):212-23.
PMID: 16083920
Analysis of transcriptome and proteome profiles by microarray technologies provides a formidable, new tool in cancer chemoprevention research. An ideal chemopreventive agent should not excessively alter per se the basal...